DORZOLAMIDE for Retinal dystrophy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where DORZOLAMIDE was used for Retinal dystrophy.
Most Reported Side Effects for DORZOLAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Treatment failure | 1,861 | 48.8% | 0 | 1 |
| Drug ineffective | 436 | 11.4% | 1 | 18 |
| Hypersensitivity | 288 | 7.6% | 0 | 9 |
| Eye irritation | 278 | 7.3% | 0 | 4 |
| Eye pain | 139 | 3.6% | 0 | 1 |
| Ocular hyperaemia | 138 | 3.6% | 0 | 8 |
| Intraocular pressure increased | 121 | 3.2% | 0 | 16 |
| Vision blurred | 118 | 3.1% | 0 | 1 |
| Drug hypersensitivity | 112 | 2.9% | 0 | 0 |
| Off label use | 81 | 2.1% | 0 | 10 |
| Dizziness | 78 | 2.1% | 0 | 5 |
| Eye pruritus | 76 | 2.0% | 0 | 2 |
| Product quality issue | 69 | 1.8% | 0 | 2 |
| Visual impairment | 61 | 1.6% | 0 | 6 |
| Product dose omission issue | 57 | 1.5% | 0 | 1 |
Other Indications for DORZOLAMIDE
Product used for unknown indication (2,412)
Glaucoma (513)
Open angle glaucoma (207)
Ocular hypertension (128)
Intraocular pressure increased (123)
Cystoid macular oedema (18)
Angle closure glaucoma (17)
Intraocular pressure test (17)
Intraocular pressure test abnormal (15)
Retinitis pigmentosa (15)